Records containing: POEMS Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-04One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
-
CLINICAL_TRIALS study record update · 2025-08-11A Prospective Single-Arm Clinical Trial of BCMA/CD3 BsAb Therapy for POEMS Syndrome
-
CLINICAL_TRIALS study record update · 2025-04-06Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
-
CLINICAL_TRIALS study record update · 2025-02-12Ixazomib, Lenalidomide, and Dexamethasone for Patients With POEMS Syndrome
-
CLINICAL_TRIALS study record update · 2024-10-30An Open Label Clinical Trial to Evaluate the Safety and Efficacy of CT103A Cells for the Treatment of Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-07-24A Phase 1 Study to Evaluate the Safety, Tolerability, Preliminary Efficacy, and Pharmacokinetic Characterization of KQ-2003 for Patients With Relapsed/Refractory POEMS Syndrome
-
CLINICAL_TRIALS study record update · 2023-11-13A Phase II Trial for the Treatment of POEMS Syndrome With Daratumumab
-
CLINICAL_TRIALS study record update · 2023-05-31Prospective, Randomized, Single Center Study to Evaluate Efficacy of Red Dichromatic Imaging (RDI) in Achieving Hemostasis During Peroral Endoscopic Myotomy Using GF 1500 UGI Scope: A Pilot Study
-
CLINICAL_TRIALS study record update · 2022-03-03A Clinical Study on the Safety and Effectiveness of CD19/BCMA Chimeric Antigen Receptor T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis
-
CLINICAL_TRIALS study record update · 2019-07-05Phase II Trial With Lenalidomide-Dexamethasone Combination in the Treatment of POEMS Syndrome.
-
CLINICAL_TRIALS study record update · 2017-04-25An Open-label Phase II Study to Determine the Efficacy and Safety of Lenalidomide Plus Dexamethasone (LDex) in Patients With Newly Diagnosed POEMS Syndrome
-
CLINICAL_TRIALS study record update · 2016-07-29Single Arm Open-label Trial to Investigate the Efficacy and Safety of Lenlidomide as a Treatment for Recurrent or Refractory Crow-Fukase (POEMS) Syndrome
-
CLINICAL_TRIALS study record update · 2010-09-02Evaluation of Efficacy and Safety of Lenalidomide (Revlimid®) in Patients With POEMS Syndrome